| Renal clearance of quantum dots | Nature Biotechnology | 2007 | 3.3K |
| PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib | Cancer Research | 2007 | 589 |
| The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease | Nature Reviews Molecular Cell Biology | 2007 | 521 |
| Germline gain-of-function mutations in SOS1 cause Noonan syndrome | Nature Genetics | 2007 | 447 |
| BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations | PLoS Medicine | 2007 | 376 |
| Compact cysteine-coated CdSe(ZnCdS) quantum dots for in vivo applications | Journal of the American Chemical Society | 2007 | 361 |
| Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets | Nature Reviews Drug Discovery | 2007 | 351 |
| Extracellular heat shock proteins in cell signaling | FEBS Letters | 2007 | 247 |
| The role of Shp2 (PTPN11) in cancer | Current Opinion in Genetics and Development | 2007 | 200 |
| B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity | Immunity | 2007 | 193 |
| Extracellular heat shock proteins in cell signaling and immunity | Annals of the New York Academy of Sciences | 2007 | 175 |
| Mechanisms for Hsp70 secretion: crossing membranes without a leader | Methods | 2007 | 149 |
| Nonreceptor protein-tyrosine phosphatases in immune cell signaling | Annual Review of Immunology | 2007 | 141 |
| Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers | Lung Cancer | 2007 | 140 |
| Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals | Proceedings of the National Academy of Sciences of the United States of America | 2007 | 133 |
| Live-cell imaging of enzyme-substrate interaction reveals spatial regulation of PTP1B | Science | 2007 | 122 |
| FOXP1: a potential therapeutic target in cancer | Expert Opinion on Therapeutic Targets | 2007 | 117 |
| SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells | Cancer Research | 2007 | 110 |
| Structural basis for high-affinity peptide inhibition of human Pin1 | ACS Chemical Biology | 2007 | 109 |
| Opportunities and obstacles to combination targeted therapy in renal cell cancer | Clinical Cancer Research | 2007 | 95 |
| Lymphatic drainage of the peritoneal space: a pattern dependent on bowel lymphatics | Annals of Surgical Oncology | 2007 | 89 |
| Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells | Cancer Research | 2007 | 75 |
| Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors | Cancer Research | 2007 | 74 |
| Synthesis of conjugatable bisphosphonates for molecular imaging of large animals | Angewandte Chemie - International Edition | 2007 | 74 |
| Real-time intraoperative ureteral guidance using invisible near-infrared fluorescence | Journal of Urology | 2007 | 73 |
